Nov. 20, 2023, 6:31 p.m. | Anne-Sophie Gill

Mila mila.quebec

MONTREAL, November 21, 2023 – Simmunome Inc., a Montreal-based techbio company leveraging generative artificial intelligence (AI) to increase the predictability of clinical drug development announces today its partnership with Mila – Quebec AI Institute, the world’s largest academic deep learning research center.  Simmunome integrates multi-omic data to generate in silico disease models that accurately capture...



Read More


The post Simmunome and Mila Announce Partnership to Advance AI in Drug Development appeared first on Mila.

academic advance artificial artificial intelligence center clinical data deep learning development drug development generate generative generative artificial intelligence institute intelligence partnership research techbio world

AI Research Scientist

@ Vara | Berlin, Germany and Remote

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Lead GNSS Data Scientist

@ Lurra Systems | Melbourne

Senior Machine Learning Engineer (MLOps)

@ Promaton | Remote, Europe

Robotics Technician - 3rd Shift

@ GXO Logistics | Perris, CA, US, 92571